Company No: 09270518 (England and Wales)

Contents

• Company Information
• Balance Sheet
• Notes to the Financial Statements

DIRECTORS	M Maslik
	M Sahm (Resigned 20 October 2025)
	F Siddiqui

REGISTERED OFFICE	Tintagel House
	92 Albert Embankment
	London
	SE1 7TY
	United Kingdom

COMPANY NUMBER

09270518 (England and Wales)

ACCOUNTANT	Gravita Business Services II Limited
	Aldgate Tower
	2 Leman Street
	London
	E1 8FA
	United Kingdom

	Note	2025		2024
		£		£
Fixed assets
Tangible assets	3	968,316		994,788
Investments	4	8		8
		968,324		994,796
Current assets
Stocks	5	201,647		921,873
Debtors	6	7,156,722		7,792,398
Cash at bank and in hand	7	19,392		879,584
		7,377,761		9,593,855
Creditors: amounts falling due within one year	8	( 8,825,556)		( 9,228,290)
Net current (liabilities)/assets		(1,447,795)		365,565
Total assets less current liabilities		(479,471)		1,360,361
Net (liabilities)/assets		( 479,471)		1,360,361
Capital and reserves
Called-up share capital		371		371
Share premium account		11,051,728		11,051,728
Other reserves		842,869		842,869
Profit and loss account		( 12,374,439 )		( 10,534,607 )
Total shareholders' (deficit)/funds		( 479,471)		1,360,361

For the financial year ending 31 October 2025 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

• The members have not required the Company to obtain an audit of its financial statements for the financial year in accordance with section 476;
• The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements; and
• These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime and a copy of the Statement of Income and Retained Earnings has not been delivered.

The financial statements of Circadia Technologies Ltd. (registered number: 09270518) were approved and authorised for issue by the Board of Directors on 29 October 2026. They were signed on its behalf by:

F Siddiqui Director

1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Circadia Technologies Ltd. (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is Tintagel House, 92 Albert Embankment, London, SE1 7TY, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Going concern

The financial statements have been prepared on a going concern basis. In assessing the appropriateness of this basis, the directors have reviewed the company's current financial position, cash flow forecasts and working capital requirements for a period of at least twelve months from the date of approval of these financial statements.

Whilst the company has incurred losses and accumulated significant deficits as it continues to invest in the development and growth of the business, subsequent to the year end it successfully completed a Series B fundraising round. Shareholders approved the investment and associated issue of new preference shares on 13 February 2026, providing additional funding to support the company's operations and growth plans.

Having considered the funds raised subsequent to the reporting date, together with forecast trading performance and available resources, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Accordingly, the financial statements have been prepared on the going concern basis.

Group accounts exemption

Group accounts exemption s399
The Company has taken advantage of the exemption under section 399 of the Companies Act 2006 not to prepare consolidated accounts, on the basis that the group of which this is the parent qualifies as a small group. The financial statements present information about the Company as an individual entity and not about its group.

Foreign currency

Transactions in foreign currencies are recorded at the rate of exchange at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies at the Balance Sheet date are reported at the rates of exchange prevailing at that date.

Exchange differences are recognised in the Statement of Income and Retained Earnings in the period in which they arise except for exchange differences arising on gains or losses on non-monetary items which are recognised in the Statement of Comprehensive Income.

Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Turnover is recognised when the significant risks and rewards are considered to have been transferred to the customer.

Employee benefits

Short term benefits
The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised as an expense when the Company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

Share-based payment

The Company issues cash-settled share based payments to certain employees within the Company. Cash-settled share based payment transactions are measured at fair value (excluding the effect of non market-based vesting conditions) at the date of grant. The fair value determined at the grant date of the cash-settled share based payments is expensed on a straight-line basis over the vesting period, based on the Group’s estimate of shares that will eventually vest and adjusted for the effect of non market-based vesting conditions.

Fair value is measured by use of the appropriate pricing model which is considered by management to be the most appropriate method of valuation. The expected life used in the model has been adjusted, based on management’s best estimate, for the effects of non-transferability, exercise restrictions, and behavioural considerations.

A liability equal to the portion of the goods or services received is recognised at and remeasured to the current fair value determined at each Balance Sheet date for cash-settled share based payments, with any changes in fair value recognised in the Statement of Income and Retained Earnings.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date.

Deferred tax
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the Company's financial statements. Deferred tax is provided in full on timing differences which result in an obligation to pay more or less tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws. Deferred tax assets and liabilities are not discounted.

The carrying amount of deferred tax assets is reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line or reducing balance basis over its expected useful life, as follows:

Office equipment	4 years straight line
Computer equipment	5 years straight line

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Leases

The Company as lessee
Assets held under finance leases, hire purchase contracts and other similar arrangements, which confer rights and obligations similar to those attached to owned assets, are capitalised as tangible fixed assets at the fair value of the leased asset (or, if lower, the present value of the minimum lease payments as determined at the inception of the lease) and are depreciated over the shorter of the lease terms and their useful lives. The capital elements of future lease obligations are recorded as liabilities, while the interest elements are charged to the Statement of Income and Retained Earnings over the period of the leases to produce a constant periodic rate of interest on the remaining balance of the liability.

Rentals under operating leases are charged on a straight-line basis over the lease term, even if the payments are not made on such a basis. Benefits received and receivable as an incentive to sign an operating lease are similarly spread on a straight-line basis over the lease term.

Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each Balance Sheet date. If there is objective evidence of impairment, an impairment loss is recognised in the Statement of Income and Retained Earnings as described below.

Non-financial assets
At each balance sheet date, the Company reviews its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss.

If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). The recoverable amount of an asset is the higher of its fair value less costs to sell and its value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

Where it is not possible to estimate the recoverable amount of an individual asset, the Company estimates the recoverable amount of the cash-generating unit to which the asset belongs. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

Fixed asset investments

Investments are recognised initially at fair value which is normally the transaction price excluding transaction costs. Subsequently, they are measured at fair value through profit or loss if the shares are publicly traded or their fair value can otherwise be measured reliably. Other investments are measured at cost less impairment.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to sell, which is equivalent to the net realisable value. Cost includes materials, direct labour and an attributable proportion of manufacturing overheads based on normal levels of activity. Cost is calculated using the FIFO (first-in, first-out) method. Provision is made for obsolete, slow-moving or defective items where appropriate.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in creditors: amounts falling due within one year.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Financial assets are derecognised when and only when the contractual rights to the cash flows from the financial asset expire or are settled, or the Company transfers to another party substantially all of the risks and rewards of ownership of the financial asset, or the Company, despite having retained some, but not all, significant risks and rewards of ownership, has transferred control of the asset to another party.

Basic financial liabilities
Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Financial liabilities are derecognised when the Company's contractual obligations expire or are discharged or cancelled.

Equity instruments
Equity instruments issued by the Company are recorded at the fair value of cash or other resources received or receivable, net of direct issue costs. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the Company.

2. Employees

	2025		2024
	Number		Number
Monthly average number of persons employed by the Company during the year, including directors	12		19

3. Tangible assets

	Office equipment		Computer equipment		Total
	£		£		£
Cost
At 01 November 2024	59,581		1,370,744		1,430,325
Additions	0		294,739		294,739
At 31 October 2025	59,581		1,665,483		1,725,064
Accumulated depreciation
At 01 November 2024	34,181		401,356		435,537
Charge for the financial year	13,639		307,572		321,211
At 31 October 2025	47,820		708,928		756,748
Net book value
At 31 October 2025	11,761		956,555		968,316
At 31 October 2024	25,400		969,388		994,788

4. Fixed asset investments

Investments in subsidiaries

	2025
	£
Cost
At 01 November 2024	8
At 31 October 2025	8
Carrying value at 31 October 2025	8
Carrying value at 31 October 2024	8

Investments in shares

Name of entity	Registered office	Principal activity	Class of shares	Ownership 31.10.2025	Ownership 31.10.2024	Held
Circadia Health Inc	1100 Glendon Ave, Suite 1555, Los Angeles 90024, United States of America	Distribution of the Circadia C100 medical device.	A	100.00%	100.00%	Direct

5. Stocks

	2025		2024
	£		£
Stocks	201,647		921,873

6. Debtors

	2025		2024
	£		£
Amounts owed by Group undertakings	6,958,116		7,081,092
Corporation tax	198,606		711,306
	7,156,722		7,792,398

7. Cash and cash equivalents

	2025		2024
	£		£
Cash at bank and in hand	19,392		879,584

8. Creditors: amounts falling due within one year

	2025		2024
	£		£
Trade creditors	49,290		56,461
Convertible loan notes	8,404,740		8,908,468
Other taxation and social security	300,297		167,474
Other creditors	71,229		95,887
	8,825,556		9,228,290

The balance within convertible loan notes relates to Simple Agreements for Future Equity issued in prior years and carried forward from the previous financial year. No conversions or settlements have been recorded during the year. The directors have confirmed that the SAFE Notes remain outstanding at the balance sheet date. The timing of any future conversion cannot presently be determined and is dependent upon the occurrence of future contractual events.

9. Related party transactions

At the year end the company was owed £12,928 (2024 : £ 12,928 )to F. Siddiqui, the director of the company, in respect of an interest free loan which is repayable on demand.

The company has taken the qualifying entries exemption available in FRS 102 not disclose related party transactions with other wholly owned group entities.

10. Events after the Balance Sheet date

Subsequent to the year end, the company completed a Series B fundraising round. On 13 February 2026, the shareholders of CIRCADIA TECHNOLOGIES LTD. approved resolutions authorising the issue of new Series B preference shares and the adoption of amended articles of association in connection with the investment round.
The funds raised have strengthened the company's working capital position and will be used to support the continued development and growth of the business. As the fundraising occurred after the reporting date of 31 October 2025, no adjustment has been made to the amounts recognised in these financial statements. The transaction has been disclosed as a non-adjusting event after the reporting period.

11. Ultimate controlling party

The director, F Siddiqui, is considered the ultimate controlling party by virtue of their shareholding.